RxDoctor Payments Data

Christopher Lee

Sports Medicine · Burbank, CANPI 1053512558

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $68,782 of the $86,009 with a category attached, or 80.0%. Medical Device Business Services, Inc. accounts for 61.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $27,141 and has fallen 82.3% since, to $4,804 in 2025. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,009in general payments, 2019–2025

Across 85 payments — averaging $1011.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$53K
  • Linvatec Corporation$20K
  • Vericel Corporation$5K
  • Depuy Synthes Products, Inc.$4K
  • Synthes USA Products LLC$1K
  • Micromed Inc$1K
  • plus $2K from 6 others

What the payments were for

  • Consulting fees$68,78280%
  • Speaking & faculty fees$7,8009%
  • Travel & lodging$5,4806%
  • Food & beverage$2,5153%
  • Education$1,4312%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$86,009 in reported general payments places this provider in the 90th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California

Medicare billing

Part B allowed, 2024
$217,761
Medicare patients
407
Services billed
1,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban22$5,698
Cephalexin77$990
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$498
Meloxicam163$475
Diclofenac Sodium46$327
Celecoxib19$278
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$126
Methylprednisolone16$85
Tramadol Hcl29$48
Ondansetron OdtOndansetron12$47

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$114$5,69822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 662 sports medicine providers in California.

Other sports medicine in Burbank

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →